Kate Broderick
Chief Tech/Sci/R&D Officer at MARAVAI LIFESCIENCES HOLDINGS, INC.
Profile
Kate E.
Broderick is currently the Senior Vice President-Research & Development at TriLink BioTechnologies LLC and the Chief Innovation Officer at Maravai Lifesciences Holdings, Inc. She previously worked at Inovio Pharmaceuticals, Inc. as the Senior Vice President-Research & Development from 2007 to 2022.
Dr. Broderick holds a doctorate degree from the University of Glasgow.
Kate Broderick active positions
| Companies | Position | Start |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
TriLink BioTechnologies LLC
 TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. The company was founded by Terry Beck and Richard Hogrefe in 1996 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
Former positions of Kate Broderick
| Companies | Position | End |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2022-06-30 |
Training of Kate Broderick
| University of Glasgow | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
TriLink BioTechnologies LLC
TriLink BioTechnologies LLC Miscellaneous Commercial ServicesCommercial Services TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets. The company was founded by Terry Beck and Richard Hogrefe in 1996 and is headquartered in San Diego, CA. | Commercial Services |
- Stock Market
- Insiders
- Kate Broderick
